314 related articles for article (PubMed ID: 8906366)
21. Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas.
Kano H; Yang HC; Kondziolka D; Niranjan A; Arai Y; Flickinger JC; Lunsford LD
J Neurosurg Pediatr; 2010 Nov; 6(5):417-23. PubMed ID: 21039163
[TBL] [Abstract][Full Text] [Related]
22. Intracranial ependymomas: analysis of prognostic factors in a population-based series.
Foreman NK; Love S; Thorne R
Pediatr Neurosurg; 1996; 24(3):119-25. PubMed ID: 8870014
[TBL] [Abstract][Full Text] [Related]
23. Intracranial ependymomas: prognostic aspects.
Ernestus RI; Wilcke O; Schröder R
Neurosurg Rev; 1989; 12(2):157-63. PubMed ID: 2779795
[TBL] [Abstract][Full Text] [Related]
24. The results of radiotherapy for ependymomas: the Mayo Clinic experience.
Schild SE; Nisi K; Scheithauer BW; Wong WW; Lyons MK; Schomberg PJ; Shaw EG
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):953-8. PubMed ID: 9869215
[TBL] [Abstract][Full Text] [Related]
25. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
26. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
27. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.
Korshunov A; Golanov A; Sycheva R; Timirgaz V
Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291
[TBL] [Abstract][Full Text] [Related]
28. Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors.
Stüben G; Stuschke M; Kroll M; Havers W; Sack H
Radiother Oncol; 1997 Oct; 45(1):3-10. PubMed ID: 9364625
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and management of intracranial ependymomas.
Papadopoulos DP; Giri S; Evans RG
Anticancer Res; 1990; 10(3):689-92. PubMed ID: 2369084
[TBL] [Abstract][Full Text] [Related]
30. Intracranial ependymomas of childhood: long-term outcome and prognostic factors.
Pollack IF; Gerszten PC; Martinez AJ; Lo KH; Shultz B; Albright AL; Janosky J; Deutsch M
Neurosurgery; 1995 Oct; 37(4):655-66; discussion 666-7. PubMed ID: 8559293
[TBL] [Abstract][Full Text] [Related]
31. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].
Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840
[TBL] [Abstract][Full Text] [Related]
32. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
Lin Y; Jea A; Melkonian SC; Lam S
J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
[TBL] [Abstract][Full Text] [Related]
33. Intracranial ependymomas in childhood. Survival and functional results of 47 cases.
Pierre-Kahn A; Hirsch JF; Roux FX; Renier D; Sainte-Rose C
Childs Brain; 1983; 10(3):145-56. PubMed ID: 6872622
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
35. Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients.
Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Gouvernet J; Jouvet A; Guyotat J
Brain; 2007 May; 130(Pt 5):1338-49. PubMed ID: 17449478
[TBL] [Abstract][Full Text] [Related]
36. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
37. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
38. Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma.
Liu AP; Shing MM; Yuen HL; Li CH; Ling SC; Luk CW; Ha SY; Li CK; Kwong DL; Chan GC
Pediatr Blood Cancer; 2014 Apr; 61(4):606-11. PubMed ID: 24167035
[TBL] [Abstract][Full Text] [Related]
39. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure.
Paulino AC; Wen BC; Buatti JM; Hussey DH; Zhen WK; Mayr NA; Menezes AH
Am J Clin Oncol; 2002 Apr; 25(2):117-22. PubMed ID: 11943886
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of postoperative residual tumor in ependymoma.
Healey EA; Barnes PD; Kupsky WJ; Scott RM; Sallan SE; Black PM; Tarbell NJ
Neurosurgery; 1991 May; 28(5):666-71; discussion 671-2. PubMed ID: 1876244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
